Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against Invasive Pneumococcal Disease incidence in European adults aged 65 years and above : results of SpIDnet/I-MOVE+ multicentre study (2012-2016)

Authors :: Savulescu, Camelia
Valentiner-Branth, P.
Mereckiene, J.
Winje, B.A.
Ciruela, P.
Latasa, P.
Guevara, M.
Carragher, Raymond Bernard
Dalby, T.
Corcoran, M.
Vestrheim, D.F.
Munoz-Almagro, C.
Sanz, J.C.
Castilla, J.
Smith, A.
Colzani, E.
Pastore-Celentano, L.
Hanquet, G.
Source :: 11th International Symposium on Pneumococci and Pneumococcal Diseases
Publication Year :: 2018
Abstract: Background and Aims: We measured the effectiveness of 23-valent pneumococcal polysaccharidic vaccine(PPV23) against invasive pneumococcal disease (IPD) in 65+ year-olds, pooling surveillance data from seven European sites. PPV23 vaccination is recommended in all sites (8-69% uptake) and PCV13 in high risk groups in two sites (

Language :: English
Database :: OpenAIRE
Journal :: 11th International Symposium on Pneumococci and Pneumococcal Diseases
Accession number :: edsair.core.ac.uk....a3a4931285c906d8b0e6660920ebd73c

Tools